Panadol Extra with Optizorb contains a clinically proven combination of medicinal ingredients. Each caplet contains paracetamol and caffeine, with advanced Optizorb technology. Panadol Extra with Optizorb is designed to fight five types of tough pain: migraine headache, period pain, tension headache, muscle aches and pains, and dental pain/toothache.
When you want tough pain relief, choose Panadol Extra with Optizorb, from Australia’s Most Trusted Pain Relief Brand.*
Get tough on tough pain. Choose Panadol Extra with Optizorb Caplets for relief of tough pain. Panadol Extra with Optizorb (pain relief caplets) doesn’t contain ibuprofen, gluten, lactose or sugar. Panadol Extra with Optizorb (pain relief caplets) contains a clinically proven combination of medicinal ingredients for fighting five types of tough pain.
Panadol Extra provides tough pain relief. When you want a tough pain reliever, choose Panadol Extra with Optizorb.
0% Customers recommend this product
Total Reviews (0)
click here write review to add review for this product.
-
(0)
-
(0)
-
(0)
-
(0)
Each caplet contains Paracetamol 500mg & Caffeine 65mg.
Age: 12 years - Adult: Take 2 caplets every 4-6 hours with water as required (Maximum 8 caplets in 24 hours).
Do not use Panadol Extra with Optizorb If you are allergic to paracetamol, caffeine or hydroxybenzoates, If using other medicines containing paracetamol or caffeine, For children below age 12, For more than 48 hours at a time for children aged 12-17 except on medical advice, For more than a few days at a time in adults except on medical advice, If pregnant, except on medical advice, If any of the seals on this packaging are broken, If the package use-by date has expired, Until you read the enclosed leaflet carefully.
Ask a doctor before use If you have liver or kidney problems, If you are taking warfarin (a medicine used to thin the blood) or If you are breastfeeding.
Stop use and see your doctor immediately if you have an allergic skin reaction, shortness of breath or wheezing after taking Panadol.
